High throughput device for screening candidate compounds for activity against target ion channels
CA 2763047 C · Owner: Vertex Pharmaceuticals (San Diego) Llc · Inventors: Maher, Michael P.; Gonzalez, Jesus E. Iii
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A high throughput screening device may comprise high-transmittance wells electrodes , disposed in the wells, and optical detection means. The device may be configured to apply an , electric field in the wells to alter the transmembrane potential of cells disposed in the wells and , produce detectable light emissions corresponding to ion channel activity.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 9, 2001 and granted August 27, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 9, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 9, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.